Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular basis for rheumatoid inflammation.

J J Cush1, P E Lipsky

  • 1Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235.

Clinical Orthopaedics and Related Research
|April 1, 1991
PubMed
Summary

Rheumatoid arthritis (RA) involves chronic inflammation driven by immune cells like CD4(+) T cells. Understanding these immunopathogenic processes is key to developing targeted treatments for RA.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A critical review of clinical trials in systemic lupus erythematosus.

Lupus·2016
Same author

Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis.

Lupus·2016
Same author

Accessory cells unrelated to mononuclear phagocytes and not of bone marrow origin.

Immunology today·2014
Same author

Interleukin 21 as a target of intervention in autoimmune disease.

Annals of the rheumatic diseases·2008
Same author

Age-related impairment of T cell proliferative responses related to the decline of CD28+ T cell subsets.

Archives of gerontology and geriatrics·2008
Same author

Measurement of human and murine interleukin 2 and interleukin 4.

Current protocols in immunology·2008

Area of Science:

  • Immunology
  • Rheumatology
  • Pathophysiology

Background:

  • Rheumatoid arthritis (RA) is a chronic, idiopathic disease causing persistent synovium inflammation, bone/cartilage destruction, and systemic issues.
  • RA pathogenesis involves significant immunologic activity, particularly CD4(+)/CD29(+) memory T cells.
  • Cytokines, inflammatory mediators, and immune complexes contribute to RA's local and systemic effects.

Purpose of the Study:

  • To elucidate the immunopathogenic mechanisms underlying rheumatoid arthritis.
  • To identify key cellular and molecular players in rheumatoid synovitis.
  • To provide insights for developing targeted RA therapies.

Main Methods:

  • Review of existing literature on rheumatoid arthritis immunopathogenesis.

Related Experiment Videos

  • Analysis of the roles of immune cells (e.g., CD4(+) T cells) and mediators (e.g., cytokines, immune complexes) in RA.
  • Examination of HLA-DR restriction in T cell responses within the synovium.

    • Main Results:

    • Rheumatoid synovitis is characterized by persistent immunologic activity, with CD4(+)/CD29(+) memory T cells playing a central role.
    • Cytokines, inflammatory mediators (arachidonic acid metabolites, vasoactive amines, PAF, complement products), and immune complexes drive RA inflammation and destruction.
    • CD4(+) T cells responding to synovium-presented antigens in an HLA-DR restricted manner are likely the primary drivers of rheumatoid inflammation.

    Conclusions:

    • Understanding the immunopathogenesis of RA, particularly the role of T cells and inflammatory mediators, is crucial.
    • Targeting specific immunologic pathways offers potential for effective and specific control of rheumatoid arthritis.
    • Further research into these mechanisms can guide the development of novel therapeutic strategies for RA.